Human Vaccines & Immunotherapeutics (Mar 2021)

Cost-effectiveness analysis has to consider all available evidence when informing inputs

  • Fabián P. Alvarez,
  • Audrey Petitjean,
  • Joshua Nealon,
  • Rosalind Hollingsworth,
  • Juan Luis López-Belmonte

DOI
https://doi.org/10.1080/21645515.2020.1799670
Journal volume & issue
Vol. 17, no. 3
pp. 694 – 695

Abstract

Read online

No abstracts available.

Keywords